Subcellular distribution of estradiol and estrone in human endometrium and myometrium during the menstrual cycle
- PMID: 6851569
- DOI: 10.1016/s0010-7824(83)80020-1
Subcellular distribution of estradiol and estrone in human endometrium and myometrium during the menstrual cycle
Similar articles
-
Metabolism of oestradiol-17 beta and oestrone in the human uterus.Acta Endocrinol (Copenh). 1975 Dec;80(4):719-31. doi: 10.1530/acta.0.0800719. Acta Endocrinol (Copenh). 1975. PMID: 1242579
-
In vivo uptake and subcellular distribution of tritium-labeled estrogens in human endometrium, myometrium, and vagina.J Clin Endocrinol Metab. 1983 Jan;56(1):76-86. doi: 10.1210/jcem-56-1-76. J Clin Endocrinol Metab. 1983. PMID: 6847874 No abstract available.
-
Extraction of estrogens by human perfused uterus. Effects of membrane permeability and binding by serum proteins on differential influx into endometrium and myometrium.Am J Obstet Gynecol. 1988 Aug;159(2):509-15. doi: 10.1016/s0002-9378(88)80119-4. Am J Obstet Gynecol. 1988. PMID: 2457321
-
Cyclic processes in the uterine tubes, endometrium, myometrium, and cervix: pathways and perturbations.Mol Hum Reprod. 2023 Apr 29;29(5):gaad012. doi: 10.1093/molehr/gaad012. Mol Hum Reprod. 2023. PMID: 37225518 Free PMC article. Review.
-
Stem/progenitor cells and the regeneration potentials in the human uterus.Reprod Med Biol. 2009 Aug 26;9(1):9-16. doi: 10.1007/s12522-009-0032-y. eCollection 2010 Mar. Reprod Med Biol. 2009. PMID: 29699326 Free PMC article. Review.
Cited by
-
Development of adverse outcome pathways relevant for the identification of substances having endocrine disruption properties Uterine adenocarcinoma as adverse outcome.EFSA J. 2023 Feb 14;21(2):e07744. doi: 10.2903/j.efsa.2023.7744. eCollection 2023 Feb. EFSA J. 2023. PMID: 36818642 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical